EcoDrugPlus

Phosphodiesterase 4b

Ensembl ID : ENSOTSG00005037631
Gene Symbol: PDE4B
3 Cross references
218 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSOTSG00005042864
Gene Symbol: PDE4B
1 Cross references
219 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSOTSG00005012120
Gene Symbol: PDE4D
1 Cross references
208 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSOTSG00005030163
Gene Symbol: PDE4D
1 Cross references
208 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSOTSG00005038091
Gene Symbol: PDE4D
3 Cross references
208 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSOTSG00005000243
Gene Symbol: PDE4D
3 Cross references
208 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSOTSG00005016750
Gene Symbol: PDE4D
1 Cross references
208 Possible Orthologues:

Phosphodiesterase 5a, Cgmp-Specific, B

Ensembl ID : ENSOTSG00005039035
Gene Symbol: PDE5AB
1 Cross references
217 Possible Orthologues:

Phosphodiesterase 5a, Cgmp-Specific, B

Ensembl ID : ENSOTSG00005032979
Gene Symbol: PDE5AB
1 Cross references
217 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSOTSG00005013611
Gene Symbol: PDE7A
3 Cross references
174 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSOTSG00005007030
Gene Symbol: PDE7A
3 Cross references
169 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSOTSG00005002984
Gene Symbol: PDE7A
1 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).